Back

Diverse activation patterns during persistent atrial fibrillation characterised by dipole density non-contact mapping

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Epidemiology of atrial fibrillation Diagnostic Methods ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Rui Shi

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

32 More presentations in this session

Presentation thumbnail
Left atrial enlargement as an independent risk factor for ischemic stroke in Japanese atrial fibrillation patients: pooled analysis of five major Japanese atrial fibrillation registries
Doctor M. Akao (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy?
Assistant Professor V. Ionin (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Clinical characteristics and outcomes of atrial fibrillation patients with thrombocytopenia: the Fushimi AF Registry
Doctor K. Ishigami (Kyoto, JP)
Abstract
Presentation thumbnail
Comparison of equations for renal function assessment and major adverse outcomes in atrial fibrillation: an analysis from the EORP-AF long-term general registry
Professor G. Boriani (Modena, IT)
Abstract
Presentation thumbnail
Temporal trends in stroke prevalence and its associations with changing patterns of antithrombotic regimens in patients with atrial fibrillation and a wide spectrum of coronary artery disease
Associate Professor B. Hudzik (Zabrze, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Epidemiology of atrial fibrillation

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources